What is the recommended treatment for trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Trichomoniasis

The recommended first-line treatment for trichomoniasis is metronidazole 500 mg orally twice daily for 7 days, which achieves cure rates of 90-95% and is superior to single-dose therapy. 1, 2, 3

Primary Treatment Regimen

  • Metronidazole 500 mg orally twice daily for 7 days is the preferred regimen based on CDC guidelines, demonstrating superior efficacy compared to single-dose therapy with cure rates of 90-95%. 1, 2, 3

  • An alternative regimen is metronidazole 2 g orally as a single dose, though this has lower efficacy. 4, 1 A landmark 2018 randomized controlled trial of 623 women demonstrated that 7-day dosing resulted in significantly fewer treatment failures (11%) compared to single-dose therapy (19%), with a relative risk of 0.55 (p<0.0001). 5

  • Tinidazole 2 g orally as a single dose is an FDA-approved alternative for trichomoniasis treatment, particularly useful in cases of metronidazole intolerance. 6, 7

Critical Management Principles

  • All sexual partners must be treated simultaneously to prevent reinfection, which is the most common cause of recurrent infection. 1, 2, 3

  • Patients must abstain from sexual activity until both partners complete treatment and are asymptomatic. 1, 2, 3

  • Patients must avoid alcohol during treatment and for at least 24 hours after completing metronidazole due to risk of disulfiram-like reaction causing nausea, vomiting, flushing, headache, and abdominal cramps. 1

Treatment Failure Algorithm

When initial treatment fails, follow this stepwise approach:

  • First treatment failure: Re-treat with metronidazole 500 mg twice daily for 7 days. 4, 1, 2, 3

  • Second treatment failure: Administer metronidazole 2 g once daily for 3-5 days. 4, 1, 2, 3

  • Persistent failure after excluding reinfection: Consult infectious disease specialist for possible drug resistance testing. 3 Metronidazole resistance is defined as minimal lethal concentration ≥50 μg/mL, and tinidazole resistance as ≥6.3 μg/mL. 8

  • Metronidazole-resistant cases: High-dose tinidazole (oral and vaginal) achieved 92% cure rate in refractory cases, with excellent tolerability. 9

Special Populations

Pregnancy

  • Metronidazole is contraindicated in the first trimester. 2, 3
  • After the first trimester, treat with metronidazole 2 g orally as a single dose. 2, 3
  • Treatment is important as trichomoniasis is associated with premature rupture of membranes and preterm delivery. 4, 3

HIV Infection

  • Use the same treatment regimens as HIV-negative patients. 4, 1, 2, 3

Metronidazole Allergy

  • Patients with immediate-type allergy may require desensitization, as effective alternatives are limited. 3
  • Tinidazole may be considered if cross-reactivity is not present. 6

Follow-Up Recommendations

  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment. 4, 1, 2, 3

  • Re-evaluate only if symptoms persist, considering reinfection (most common) or resistant infection. 2, 3

Critical Pitfalls to Avoid

  • Never use topical metronidazole gel for trichomoniasis - it has efficacy <50% and fails to achieve therapeutic levels in the urethra and perivaginal glands where the organism resides. 1, 2, 3

  • Do not rely on negative cultures in male partners to exclude infection, as isolation from asymptomatic males is difficult. 4

  • Ensure medication adherence is addressed, as the 7-day regimen requires patient commitment (though adherence rates are typically 96%). 5

References

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomoniasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Single dose treatment of trichomoniasis.

The Journal of international medical research, 1982

Research

Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.